Pharmaceuticals news FT.com

Higher medicine sales tax makes UK ‘uninvestable’, warn...

Industry lobby group calls for action from government ahead of summit in April

Higher medicine sales tax makes UK ‘uninvestable’, drug...

Industry lobby group calls for action from government ahead of summit in April

Trump funding cuts will ‘kneecap’ US innovation, univer...

Academic institutions have been forced to freeze new hires and limit PhD places

AstraZeneca buys cell therapy biotech in up to $1bn deal

London-listed pharmaceuticals group expands investments in cancer cell therapies...

Novo Nordisk foundation’s obesity head works as paid ad...

Professor Arne Astrup is also involved in project to change widely-accepted defi...

Drugmaker merger turns the page on a dark chapter of US...

Real-world pain lies behind a big win for several Wall Street vulture funds

White House withdraws nomination of vaccine-sceptic pic...

U-turn on candidacy of Dave Weldon to lead Centers for Disease Control a rare se...

Mallinckrodt and Endo to combine after emerging from ba...

Groups have resolved billions of dollars in claims for selling highly addictive ...

China’s obesity crisis is big business

Pharmaceutical groups are rushing to dominate market that will grow to 900mn peo...

Roche agrees biggest-ever obesity drug deal

Swiss pharma group signs $5.3bn licensing agreement for next-generation treatmen...

Roche signs biggest-ever obesity drug deal

Swiss pharma group agrees $5.3bn licensing agreement for next-generation treatme...

Novo Nordisk shares fall on latest trial results for ne...

Participants with type 2 diabetes had an average weight loss of 15.7 per cent af...

Manchester looks to build on life sciences cluster effect

The city’s ecosystem of universities, commerce and research is attracting invest...

Hikma races to launch generic versions of blockbuster o...

Pharma group looks to take advantage as Wegovy and Ozempic start to go off paten...

Sycamore to take Walgreens private in up to $24bn deal

Buyout of group behind Boots will bring to an end the drugstore chain’s century-...

Bayer warns of third straight year of falling profits a...

Chief executive raises hope for recovery from 2026

Bayer warns of third successive year of falling profits...

Chief executive raises hope for recovery from 2026 onwards

Protein project uses AI to boost disease treatment

UK initiative to harness big biological data sets and look deeper into how the h...

Drugmakers prepare to sue EU over tax to pay for wastew...

Pharma and cosmetics industries want other sectors to contribute ‘fair share’ to...

Bayer’s turnaround man faces ‘crucial’ year at ailing c...

Bill Anderson ‘stands and falls’ with direction of European group’s flagging sha...

Drugmakers prepare to sue EU over tax to pay for waste ...

Pharma and cosmetics industries want other sectors to contribute ‘fair share’ to...

Stockpickers: Indivior highlights the difficulty of fin...

Battles with regulators, legal wrangles and threats from generic makers add to t...

What went wrong after Walgreens bought Boots?

Transatlantic drugstore empire explores possible break-up after strategic mis-st...

Psychiatric drug research held back by ‘stigma’, says t...

Mental health treatments face higher regulatory hurdles for approval, warns Impe...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.